{
  "DOI": "10.1007/s10689-023-00342-3",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-023-00342-3",
  "alternative-id": [
    "342"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "6 March 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "5 June 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "24 June 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Dr. Kevin S. Hughes receives honoraria from Hologic (Surgical implant for radiation planning with breast conservation and wire-free breast biopsy), TME (Targeted Medical Education, genetics education and consulting), MedNeon (Genetics education company), and Myriad Genetics. Dr. Hughes has a financial interest in CRA Health (Formerly Hughes RiskApps) which was recently acquired by Volpara. CRA Health develops risk assessment models/software with a particular focus on breast cancer and colorectal cancer. Dr. Hughes is the founder of the company. Dr. Hughes is the Co-Creator of Ask2Me.Org which is freely available for clinical use and is licensed for commercial use by the Dana Farber Cancer Institute and the Massachusetts General Hospital. Dr. Hughes’s interests in CRA Health and Ask2Me.Org were reviewed and are managed by Massachusetts General Hospital and Partners Health Care in accordance with their conflict-of-interest policies. The other authors declare that they have no conflict of interest."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "This project was a quality improvement project following the Standards for Quality Improvement Reporting Excellence (SQUIRE) reporting guideline and therefore was exempt from Institutional Review Board approval."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Chai",
      "given": "Teresa S.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Yin",
      "given": "Kanhua",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wooters",
      "given": "Mackenzie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Shannon",
      "given": "Kristen M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hughes",
      "given": "Kevin S.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        6,
        24
      ]
    ],
    "date-time": "2023-06-24T11:46:34Z",
    "timestamp": 1687607194000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        9,
        29
      ]
    ],
    "date-time": "2023-09-29T14:55:00Z",
    "timestamp": 1695999300000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        12,
        4
      ]
    ],
    "date-time": "2023-12-04T21:54:17Z",
    "timestamp": 1701726857245
  },
  "is-referenced-by-count": 1,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2023,
        6,
        24
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2023,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            6,
            24
          ]
        ],
        "date-time": "2023-06-24T00:00:00Z",
        "timestamp": 1687564800000
      }
    },
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            6,
            24
          ]
        ],
        "date-time": "2023-06-24T00:00:00Z",
        "timestamp": 1687564800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-023-00342-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-023-00342-3/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-023-00342-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "467-474",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2023,
        6,
        24
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        6,
        24
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2023,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "342_CR1",
      "unstructured": "Genetic/familial high-risk assessment : Breast, ovarian, and pancreatic (version 1, 2021). National Comprehensive Cancer Network. URL: https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf [Accessed 10 12 2021  ]"
    },
    {
      "key": "342_CR2",
      "unstructured": "Genetic/familial high-risk assessment : Colorectal (version 1, 2021). National Comprehensive Cancer Network. URL: https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf [Accessed 10 12 2021  ]"
    },
    {
      "key": "342_CR3",
      "unstructured": "Prostate cancer early detection (2021) National Comprehensive Cancer Network. URL: https://www.nccn.org/professionals/physician_gls/pdf/prostate_detection.pdf [Accessed 10 12 2021  ]"
    },
    {
      "DOI": "10.1200/JCO.2017.73.6314",
      "author": "CP Childers",
      "doi-asserted-by": "publisher",
      "first-page": "3800",
      "issue": "34",
      "journal-title": "J Clin Oncol",
      "key": "342_CR4",
      "unstructured": "Childers CP, Childers KK, Maggard-Gibbons M, Macinko J (2017) National estimates of genetic testing in Women with a history of breast or ovarian Cancer. J Clin Oncol 35(34):3800–3806",
      "volume": "35",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.2017.74.7899",
      "author": "KS Hughes",
      "doi-asserted-by": "publisher",
      "first-page": "3789",
      "issue": "34",
      "journal-title": "J Clin Oncol",
      "key": "342_CR5",
      "unstructured": "Hughes KS (2017) Genetic testing: what problem are we trying to solve. J Clin Oncol 35(34):3789–3791",
      "volume": "35",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s12687-020-00499-9",
      "author": "SK Rao",
      "doi-asserted-by": "publisher",
      "first-page": "129",
      "issue": "1",
      "journal-title": "J Community Genet",
      "key": "342_CR6",
      "unstructured": "Rao SK, Thomas KA, Singh R, Biltibo E, Lammers PE, Wiesner GL (2021) Increased ease of access to genetic counseling for low-income women with breast cancer using a point of care screening tool. J Community Genet 12(1):129–136",
      "volume": "12",
      "year": "2021"
    },
    {
      "DOI": "10.1038/gim.2015.98",
      "author": "S Knapke",
      "doi-asserted-by": "publisher",
      "first-page": "410",
      "issue": "4",
      "journal-title": "Genet Med",
      "key": "342_CR7",
      "unstructured": "Knapke S, Haidle JL, Nagy R, Pirzadeh-Miller S (2016) The current state of cancer genetic counseling access and availability. Genet Med 18(4):410–412",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1200/JOP.2016.013581",
      "author": "P Whitworth",
      "doi-asserted-by": "publisher",
      "first-page": "e47",
      "issue": "1",
      "journal-title": "J Oncol Pract",
      "key": "342_CR8",
      "unstructured": "Whitworth P, Beitsch P, Arnell C et al (2017) Impact of payer constraints on access to genetic testing. J Oncol Pract 13(1):e47–e56",
      "volume": "13",
      "year": "2017"
    },
    {
      "DOI": "10.1186/s13053-022-00213-5",
      "author": "KR Muessig",
      "doi-asserted-by": "publisher",
      "first-page": "7",
      "issue": "1",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "342_CR9",
      "unstructured": "Muessig KR, Zepp JM, Keast E et al (2022) Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system. Hered Cancer Clin Pract 20(1):7",
      "volume": "20",
      "year": "2022"
    },
    {
      "DOI": "10.1038/ejhg.2014.180",
      "author": "T Delikurt",
      "doi-asserted-by": "publisher",
      "first-page": "739",
      "issue": "6",
      "journal-title": "Eur J Hum Genet",
      "key": "342_CR10",
      "unstructured": "Delikurt T, Williamson GR, Anastasiadou V, Skirton H (2015) A systematic review of factors that act as barriers to patient referral to genetic services. Eur J Hum Genet 23(6):739–745",
      "volume": "23",
      "year": "2015"
    },
    {
      "DOI": "10.1038/s41431-021-00848-3",
      "author": "C Beard",
      "doi-asserted-by": "publisher",
      "first-page": "872",
      "issue": "5",
      "journal-title": "Eur J Hum Genet",
      "key": "342_CR11",
      "unstructured": "Beard C, Monohan K, Cicciarelli L, James PA (2021) Mainstream genetic testing for breast cancer patients: early experiences from the Parkville Familial Cancer Centre. Eur J Hum Genet 29(5):872–880",
      "volume": "29",
      "year": "2021"
    },
    {
      "DOI": "10.1038/srep29506",
      "author": "A George",
      "doi-asserted-by": "publisher",
      "first-page": "29506",
      "journal-title": "Sci Rep",
      "key": "342_CR12",
      "unstructured": "George A, Riddell D, Seal S et al (2016) Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients. Sci Rep 6:29506",
      "volume": "6",
      "year": "2016"
    },
    {
      "DOI": "10.1136/bmjqs-2015-004411",
      "author": "G Ogrinc",
      "doi-asserted-by": "publisher",
      "first-page": "986",
      "issue": "12",
      "journal-title": "BMJ Qual Saf",
      "key": "342_CR13",
      "unstructured": "Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D (2016) SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf 25(12):986–992",
      "volume": "25",
      "year": "2016"
    },
    {
      "DOI": "10.1245/s10434-019-07549-8",
      "author": "ER Manahan",
      "doi-asserted-by": "publisher",
      "first-page": "3025",
      "issue": "10",
      "journal-title": "Ann Surg Oncol",
      "key": "342_CR14",
      "unstructured": "Manahan ER, Kuerer HM, Sebastian M et al (2019) Consensus guidelines on genetic testing for hereditary breast cancer from the American society of breast surgeons. Ann Surg Oncol 26(10):3025–3031",
      "volume": "26",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s10689-020-00160-x",
      "author": "EM Grindedal",
      "doi-asserted-by": "publisher",
      "first-page": "133",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "342_CR15",
      "unstructured": "Grindedal EM, Jørgensen K, Olsson P et al (2020) Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway. Fam Cancer 19(2):133–142",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1177/1359105316689141",
      "author": "N Mahmoodi",
      "doi-asserted-by": "publisher",
      "first-page": "1082",
      "issue": "8",
      "journal-title": "J Health Psychol",
      "key": "342_CR16",
      "unstructured": "Mahmoodi N, Sargeant S (2019) Shared decision-making - rhetoric and reality: Women’s experiences and perceptions of adjuvant treatment decision-making for breast cancer. J Health Psychol 24(8):1082–1092",
      "volume": "24",
      "year": "2019"
    },
    {
      "DOI": "10.1200/JCO.20.00299",
      "author": "NM Tung",
      "doi-asserted-by": "publisher",
      "first-page": "2080",
      "issue": "18",
      "journal-title": "J Clin Oncol",
      "key": "342_CR17",
      "unstructured": "Tung NM, Boughey JC, Pierce LJ et al (2020) Management of hereditary breast cancer: American society of clinical oncology, American society for radiation oncology, and society of surgical oncology guideline. J Clin Oncol 38(18):2080–2106",
      "volume": "38",
      "year": "2020"
    },
    {
      "DOI": "10.1056/NEJMoa2105215",
      "author": "ANJ Tutt",
      "doi-asserted-by": "publisher",
      "first-page": "2394",
      "issue": "25",
      "journal-title": "N Engl J Med",
      "key": "342_CR18",
      "unstructured": "Tutt ANJ, Garber JE, Kaufman B et al (2021) Adjuvant olaparib for patients with BRCA1- or BRCA2-Mutated breast Cancer. N Engl J Med 384(25):2394–2405",
      "volume": "384",
      "year": "2021"
    },
    {
      "DOI": "10.1056/NEJMoa1706450",
      "author": "M Robson",
      "doi-asserted-by": "publisher",
      "first-page": "523",
      "issue": "6",
      "journal-title": "N Engl J Med",
      "key": "342_CR19",
      "unstructured": "Robson M, Im SA, Senkus E et al (2017) Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med 377(6):523–533",
      "volume": "377",
      "year": "2017"
    },
    {
      "DOI": "10.1001/jama.2014.12483",
      "author": "MC King",
      "doi-asserted-by": "publisher",
      "first-page": "1091",
      "issue": "11",
      "journal-title": "JAMA",
      "key": "342_CR20",
      "unstructured": "King MC, Levy-Lahad E, Lahad A (2014) Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award. JAMA 312(11):1091–1092",
      "volume": "312",
      "year": "2014"
    },
    {
      "DOI": "10.1245/s10434-022-11860-2",
      "author": "KS Hughes",
      "doi-asserted-by": "publisher",
      "first-page": "4667",
      "issue": "8",
      "journal-title": "Ann Surg Oncol",
      "key": "342_CR21",
      "unstructured": "Hughes KS, Yin K (2022) A woman needs to know she is a BRCA carrier before she develops breast Cancer. Ann Surg Oncol 29(8):4667–4669",
      "volume": "29",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.critrevonc.2022.103797",
      "author": "M Charron",
      "doi-asserted-by": "publisher",
      "first-page": "103797",
      "journal-title": "Crit Rev Oncol Hematol",
      "key": "342_CR22",
      "unstructured": "Charron M, Kaiser B, Dauge A et al (2022) Integrating hereditary breast and ovarian cancer genetic counselling and testing into mainstream clinical practice: legal and ethical challenges. Crit Rev Oncol Hematol 178:103797",
      "volume": "178",
      "year": "2022"
    },
    {
      "DOI": "10.1200/JCO.2020.38.15_suppl.1506",
      "author": "EM Swisher",
      "doi-asserted-by": "publisher",
      "first-page": "1506",
      "issue": "15 suppl",
      "journal-title": "J Clin Oncol",
      "key": "342_CR23",
      "unstructured": "Swisher EM, Rayes N, Bowen D et al (2020) Results from MAGENTA: a national randomized four-arm noninferiority trial evaluating pre- and post-test genetic counseling during online testing for breast and ovarian cancer genetic risk. J Clin Oncol 38(15 suppl):1506",
      "volume": "38",
      "year": "2020"
    },
    {
      "DOI": "10.1089/gtmb.2022.0160",
      "author": "T Pal",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Genet Test Mol Biomarkers",
      "key": "342_CR24",
      "unstructured": "Pal T, Shah P, Weidner A et al (2023) Inherited Cancer knowledge among black females with breast Cancer before and after viewing a web-based Educational Video. Genet Test Mol Biomarkers 27(1):1–4",
      "volume": "27",
      "year": "2023"
    },
    {
      "DOI": "10.1002/jgc4.1345",
      "author": "AM Aeilts",
      "doi-asserted-by": "publisher",
      "first-page": "656",
      "issue": "3",
      "journal-title": "J Genet Couns",
      "key": "342_CR25",
      "unstructured": "Aeilts AM, Carpenter KM, Hovick SR, Byrne L, Shoben AB, Senter L (2021) The impact of a cascade testing video on recipients’ knowledge, cognitive message processing, and affective reactions: a formative evaluation. J Genet Couns 30(3):656–664",
      "volume": "30",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s10689-021-00261-1",
      "author": "B Meiser",
      "doi-asserted-by": "publisher",
      "first-page": "157",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "342_CR26",
      "unstructured": "Meiser B, Woodward P, Gleeson M et al (2022) Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients. Fam Cancer 21(2):157–166",
      "volume": "21",
      "year": "2022"
    },
    {
      "DOI": "10.3390/cancers13112729",
      "author": "J Lapointe",
      "doi-asserted-by": "publisher",
      "first-page": "2729",
      "issue": "11",
      "journal-title": "Cancers (Basel)",
      "key": "342_CR27",
      "unstructured": "Lapointe J, Dorval M, Chiquette J et al (2021) A collaborative model to implement flexible, accessible and efficient Oncogenetic Services for Hereditary breast and ovarian Cancer: the C-MOnGene study. Cancers (Basel) 13(11):2729",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s10549-018-5000-y",
      "author": "MP Nilsson",
      "doi-asserted-by": "publisher",
      "first-page": "313",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "342_CR28",
      "unstructured": "Nilsson MP, Nilsson ED, Borg Ã, Brandberg Y, Silfverberg B, Loman N (2019) High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study. Breast Cancer Res Treat 173(2):313–318",
      "volume": "173",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s13053-022-00238-w",
      "author": "K Bokkers",
      "doi-asserted-by": "publisher",
      "first-page": "33",
      "issue": "1",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "342_CR29",
      "unstructured": "Bokkers K, Bleiker EMA, Hoogendam JP et al (2022) Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing. Hered Cancer Clin Pract 20(1):33",
      "volume": "20",
      "year": "2022"
    }
  ],
  "reference-count": 29,
  "references-count": 29,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-023-00342-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Mainstreamed genetic testing of breast cancer patients: experience from a single surgeon’s practice in a large US Academic Center"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "22"
}